BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 15, 2010
View Archived Issues
Pritumumab is active in patients with brain cancer
Read More
GlycoVaxyn reports phase I data on Shigella dysenteriae vaccine
Read More
IPI-926 is well tolerated and active in patients with solid tumors
Read More
GAA peptide-loaded DC1-based vaccine shows promise in recurrent malignant glioma
Read More
French scientists claim new inhibitors of cell division protein kinases
Read More
Prosidion describes new GPR119 receptor agonists
Read More
Continuous exenatide delivery with ITCA-650 shows promise in phase II diabetes trial
Read More
Preclinical and phase I data presented on Algipharma's OligoG
Read More
Takeda and Envoy Therapeutics collaborate on schizophrenia research
Read More
UCB and Synosia Therapeutics enter into strategic neurology alliance
Read More
Novartis renews agreement with WHO to provide free leprosy drugs
Read More
Bazedoxifene launched in Japan and Spain for postmenopausal osteoporosis
Read More
Almirall presents pharmacological profile of LAS-189913, a new candidate therapeutic for MS
Read More
Bristol-Myers Squibb acquires ZymoGenetics
Read More
First patient with spinal cord injury is treated in phase I trial of GRNOPC1
Read More
FDA funds phase I trial of genetically reprogrammed HSV in childhood cancer
Read More
Phase II trial studies sildenafil for heart failure in Duchenne's muscular dystrophy
Read More
Pfizer to acquire King Pharmaceuticals and expand pain product portfolio
Read More
FDA warns of increased risk of thigh bone fracture with bisphosphonates use
Read More
Merck & Co. claims new diacylglycerol O-acyltransferase 1 inhibitors
Read More
Olatec Industries patents agents with anti-inflammatory and analgesic potential
Read More
New deuterated alpha-(N-sulfonamido)acetamide beta-APP42 production inhibitors claimed
Read More
ERYtech and Genzyme to conduct feasibility studies with new therapeutic enzyme formulation
Read More
Shire acquires 99.21% of Movetis shares, proceeding with squeeze-out of remaining shares
Read More
Twice-daily tramadol/acetaminophen approved in eight European countries
Read More
Innate Therapeutics begins phase II trial of MIS-416 in progressive MS
Read More